The Utility of House Calls in Pulmonary Disease
Pulmonologists may decide to provide a one-time house call after hospitalization, which has been shown to improve outcomes and reduce readmissions, including in patients with COPD.
Chronic Obstructive Pulmonary Disease
COPD Subtype Classification: Analysis of the COPDGene Study
Continuous evaluation of participants in the COPDGene study will provide useful insights that will enable better identification of disease subtypes.
Increased Nutrient Intake Linked With Decreased COPD Severity in Elderly Men
Among elderly men with COPD, proper intake of fiber, protein, carbohydrate, vitamin C, niacin, and riboflavin was associated with less severe airway impairment.
Virtual vs In-Person Education for Inhaler Use in Asthma, COPD
Hospitalized patients with asthma or COPD who received virtual inhaler use education via a tablet was as effective as in person education.
Varenicline Initially Improves Continuous Abstention in Smokers With COPD
Patients who smoked and were hospitalized for a COPD exacerbation had higher rates of continuous abstention when treated with both varenicline and intensive counseling compared with intensive counseling alone.
High Patient Complexity in COPD Associated With Low-Value ICS Prescription
Higher patient complexity is associated with incident prescription of low-value inhaled corticosteroids in COPD.
Could COPD Serve as a Marker of Cardiovascular Morbidity, Mortality?
Patients with chronic obstructive pulmonary disease experience significant cardiovascular morbidity and mortality.
COPD Prevalence, Diagnosis, and Mortality: Differences Between Women and Men
Women were more likely than men to be diagnosed with chronic obstructive pulmonary disease, and had more frequent exacerbations.
COPD Severity Affected by Traffic-Related Air Pollution
Acute exposure to traffic-related air pollution can lead to lower airway neutrophils to release of neutrophil extracellular traps, which is linked to COPD severity and airflow limitations.
COPD Assessment Test Submitted to FDA for Drug Development Tool Approval
Researchers have proposed that the COPD Assessment Test (CAT) be used as a US Food and Drug Administration (FDA) clinical outcomes assessment tool.
Next post in COPD
